HAOHAI BIOTEC
68836631.441.91% ( +0.59 )
HAOHAI BIOTEC (688366)
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, t...
- Open
- 31.08
- High
- 31.98
- Low
- 30.81
- Prev. Close
- 30.85
- Volume
- 8.40K
- Turnover
- 26.44M
- Avg Price
- 31.47
- Bid/Ask Ratio
- --
- Amplitude
- 3.79%
- 52wk High
- 57.97
- Volume Ratio
- 0.80
- Turnover Ratio
- 0.43%
HAOHAI BIOTEC Analyst Rating
View MoreForecast & Rating
Apr 1, 2026Price forecast
¥45.0043.13%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jun 22 at 04:18 AM
Shanghai Haohai Biological Tech files HKEX next-day return disclosing share cancellation after repurchase at HKD 22.17
- Tip Ranks · Apr 30 at 09:03 AM
Shanghai Haohai Says Controlling Shareholder Released on Bail in Unrelated Insider Trading Case
- Tip Ranks · Mar 10 at 03:40 AM
Haohai Biological Sets March 2026 Board Meeting to Review 2025 Results and Dividend Plan
- AASTOCKS · Mar 1 at 03:19 AM
According to "Performance," HAOHAI BIOTEC's net profit last year was 251 million RMB, a decline of 40.3%
- Wallstreetcn · Feb 10 at 01:53 AM
National Health Commission: Beauty institutions, hair salons, nail salons, and other lifestyle-related businesses are strictly prohibited from conducting "light medical beauty" projects
- Tip Ranks · Dec 23, 2025 at 07:09 AM
Haohai Biotec Discloses CSRC Penalty Against Controlling Shareholder for Unrelated Insider Trading Case
